Acro Biomedical (ACBM) Invested Capital (2015 - 2025)
Acro Biomedical's quarterly Invested Capital came in at -$386964.0 in Q4 2025, down 31.19% year-on-year from -$562338.9 in Q4 2024, and up 10.55% quarter-over-quarter from -$432619.0 in Q3 2025.
Acro Biomedical has reported Invested Capital for 11 years, with the latest figure at -$386964.0 in Q4 2025.
- For the quarter ending Q4 2025, Invested Capital fell 31.19% year-over-year to -$386964.0; the trailing twelve-month figure through Dec 2025 stood at -$386964.0 (down 31.19% YoY), and the FY2025 full-year result was -$386964.0, down 31.19% from the prior year.
- Invested Capital for Q4 2025 stood at -$386964.0, up from -$432619.0 in the prior quarter.
- The five-year high for Invested Capital was $886444.0 in Q1 2021, with the low at -$432619.0 in Q3 2025.
- Average Invested Capital over 5 years is $143998.4, with a median of $50020.5 recorded in 2023.
- Year-over-year, Invested Capital slipped 2.91% in 2022 and sank 181.38% in 2024.
- Tracing ACBM's Invested Capital over 5 years: stood at $664448.0 in 2021, then slipped by 14.94% to $565196.0 in 2022, then tumbled by 145.47% to -$257014.0 in 2023, then decreased by 14.77% to -$294972.0 in 2024, then sank by 31.19% to -$386964.0 in 2025.
- The last three Invested Capital figures came in at -$386964.0 (Q4 2025), -$432619.0 (Q3 2025), and -$317520.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -16.30 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | -12.19 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | -13.79 Mn |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | -11.23 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | -29.19 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | -16.14 Mn |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | -8.10 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | -14.01 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | -8.10 Mn |
| 10 | Acro Biomedical | - | - | - | -386,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -386,964.00 |
| Sep 30, 2025 | -432,619.00 |
| Jun 30, 2025 | -317,520.00 |
| Mar 31, 2025 | -303,906.00 |
| Dec 31, 2024 | -294,972.00 |
| Sep 30, 2024 | -285,504.00 |
| Jun 30, 2024 | -276,398.00 |
| Mar 31, 2024 | -267,312.00 |
| Dec 31, 2023 | -257,014.00 |
| Sep 30, 2023 | -239,613.00 |
| Jun 30, 2023 | 339,654.00 |
| Mar 31, 2023 | 410,904.00 |
| Dec 31, 2022 | 565,196.00 |
| Sep 30, 2022 | 570,758.00 |
| Jun 30, 2022 | 596,132.00 |
| Mar 31, 2022 | 664,248.00 |
| Dec 31, 2021 | 664,448.00 |
| Sep 30, 2021 | 587,868.00 |
| Jun 30, 2021 | 656,139.00 |
| Mar 31, 2021 | 886,444.00 |
| Dec 30, 2020 | 928,819.00 |
| Sep 30, 2020 | 933,454.00 |
| Jun 30, 2020 | 940,619.00 |
| Mar 31, 2020 | 941,814.00 |
| Dec 31, 2019 | 824,518.00 |
| Sep 30, 2019 | 935,440.00 |
| Jun 30, 2019 | 1.05 Mn |
| Mar 31, 2019 | 1.02 Mn |
| Dec 31, 2018 | 1.17 Mn |
| Sep 30, 2018 | 1.38 Mn |
| Jun 30, 2018 | 917,755.00 |
| Mar 31, 2018 | 756,304.00 |
| Dec 31, 2017 | 632,929.00 |
| Sep 30, 2017 | 547,710.00 |
| Jun 30, 2017 | -1,900.00 |
| Mar 31, 2017 | -7,567.00 |
| Dec 31, 2016 | -12,206.00 |
| Sep 30, 2016 | -4,793.00 |
| Jun 30, 2016 | -8,666.00 |
| Mar 31, 2016 | 8,459.00 |
| Sep 30, 2015 | 28,635.00 |